Hancock Whitney Corp Syros Pharmaceuticals, Inc. Transaction History

Hancock Whitney Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 04, 2021	SELL	$4.08 - $5.66 $113,668 - $157,687	-27,860 Closed	0 $0
Q2 2021 Aug 09, 2021	BUY	$5.01 - $7.48 $83,125 - $124,108	16,592 Added 147.25%	27,860 $152,000
Q1 2021 May 14, 2021	SELL	$7.19 - $14.95 $15,005 - $31,200	-2,087 Reduced 15.63%	11,268 $84,000
Q3 2020 Nov 05, 2020	BUY	$8.69 - $14.47 $116,054 - $193,246	13,355 New	13,355 $118,000

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $43.1M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Hancock Whitney Corp, based on Form 13F filings with the SEC.

Stay updated on Hancock Whitney Corp with notifications on news.